Purified MPXV A29L Molecule (His Label): A Research Resource
Purified MPXV A29L Molecule (His Label): A Research Resource
Blog Article
This produced Monkeypox Protein A29 protein, equipped with a His marker, represents a valuable research tool for investigation of viral functions and candidate therapeutic targets. The His label allows for easy purification and assessment using standard immobilized chromatography, making it suitable for a range of experiments including immune binding studies, structure determination, and component expression experiments. Thus, this engineered component offers a reproducible means to advance knowledge of Orthopoxvirus pathogenesis.
Production and Characterization of Recombinant MPXV A29L Protein (His Tag)
The successful production of recombinant MPXV A29L molecule, modified with a His sequence, was obtained using *E. coli* transcription system. Initial steps involved inserting the A29L gene into a plasmid system followed by transfection into competent *E. coli* cultures. Following, refined fermentation settings were determined to maximize production. Isolation of the His-tagged A29L protein was performed utilizing immobilized metal affinity separation. Analysis involved techniques such as SDS-PAGE, Western blotting, and mass spectrometry to verify specificity and determine estimated weight and cleanliness. The resulting recombinant A29L molecule exhibited appropriate size and indicated the presence of the His sequence, supporting adequate expression and recovery.
Recombinant Orthopoxvirus A29L Protein (His Tag|with a His-tag|His-tagged) for Orthopoxvirus Studies
The provision of recombinant MPXV A29L molecule (His Label) provides a critical tool for advancing investigations into the mechanism of monkeypox infection. This molecule facilitates easy quantification and purification through metal chromatography, permitting for detailed characterization of its functional properties, binding with immune factors, and potential in viral Recombinant MPXV A29L Protein(His Tag) replication. The His tag serves as a convenient means for simple production and purification, making it particularly suited for a spectrum of orthopoxvirus experiments.
Optimizing Production of Recombinant MPXV A29L Compound (His Tag | with a His Tag | tagged with His | featuring a His tag)
To achieve improved yields of the produced MPXV A29L factor , various aspects require meticulous regulation. Early attempts involved routine generation in *E. coli*, however, this often resulted in reduced output and substantial inclusion body formation. Consequently , methods such as adjusting the promoter strength, fine-tuning the growth environment , and employing aiding components to promote proper folding were utilized . Furthermore , exploring different production systems , such as yeast , is being examined to even increase yield and boost factor performance.
Applications of Recombinant MPXV A29L Protein (His Tag) in Diagnostics
Recombinant MPXV A29L molecule (His marker) exhibits significant application in improving reliable detection tests for monkeypox disease. Its utilization as a target in ELISA and point-of-care detection systems enables for specific recognition of immunoglobulins from exposed patients. The His marker aids isolation and assessment of the modified A29L molecule, consequently improving the total efficacy and specificity of the identification protocol. Further research into its integration into simultaneous diagnostic arrays persists a encouraging domain of exploration.
Recombinant MPXV A29L Antigen (His Tag) Supply and Characteristics
The engineered A29L antigen from Orthopoxvirus, featuring a His-affinity for easy isolation, is now offered for research use. The substance is produced in bacteria and furnished as a lyophilized form, permitting for stable storage. Typical details include a size of approximately 140 kDa, >90% cleanliness as assessed by SDS-PAGE and a amount of 1 mg/mL in a solution of salt solution. See the data document for complete data regarding delivery conditions and suggested keeping protocols.
Report this page